CSL Behring evaluates monoclonal antibody in Covid-19 patients

Divya Tirumalaraju ]]> This scanning electron microscope image shows SARS-CoV-2 (round gold objects) emerging from the surface of cells cultured in the lab. Credit: NIAID-RML. Sign up here for GlobalData’s free bi-weekly Covid-19 report on the latest information…

Coronavirus Vaccine | COVAXIN: Human trials of India’s first COVID-19 vaccine on 375 people to begin soon

TIMESNOW COVAXIN: Human trials of India’s first COVID-19 vaccine on 375 people to begin soon&nbsp Key Highlights India’s first indigenous coronavirus vaccine ‘COVAXIN’ successfully enters human trials The vaccine will be tested on more than…

Immune Regulation and DynPort to trial Covid-19 drug candidate

Divya Tirumalaraju ]]> A computer generated representation of Covid-19 virions (SARS-CoV-2) under electron microscope. Credit: Felipe Esquivel Reed. Sign up here for GlobalData’s free bi-weekly Covid-19 report on the latest information your industry needs to know. Biotechnology company…

Johns Hopkins Reports Promising Clinical Data in COVID-19 ARDS Treated with Cellenkos’ Cord Blood T-Regulatory Cells

Cellenkos, Inc. HOUSTON, July 6, 2020 /CNW/ — Physician-investigators at Johns Hopkins University Hospital report on the promising data of treatment of COVID-19 induced acute respiratory distress syndrome with allogeneic, cord blood derived T-regulatory (Treg) cell therapy (manufactured by…

Human trials of Covaxin, India’s first Covid-19 vaccine, to begin soon: All you need to know – india news

Hindustan Times India’s first potential indigenous coronavirus disease (Covid-19) vaccine, Covaxin, has been jointly developed by the Indian Council of Medical Research (ICMR) and Bharat Biotech International Limited (BBIL). ICMR had written to 12 institutes where human trials…

The race for a Covid-19 vaccine

Anne Moore Analysis: what’s going on with the search for a vaccine – and what does Ireland need to do to increase its research in this area? The endgame to the Covid-19 pandemic needs the identification and manufacture of…

Deadline of Aug 15 for Covid-19 vaccine unrealistic: Indian Academy of Sciences – india news

Hindustan Times The Bengaluru-based Indian Academy of Sciences has said that the Indian Council for Medical Research’s (ICMR) aim to launch a vaccine for the coronavirus infection by August 15 is simply “unfeasible” as well as “unrealistic”. Admitting…

COVAXIN controversy: Doctors in trial sites chosen by ICMR say human trials can’t be fast forwarded, anticipate 6-month observation period

Firstpost Hyderabad-based Bharat Biotech received approval from the Central Drugs Standard Control Organisation (CDSCO) to begin human trials of COVAXIN last week. The vaccine has been developed in collaboration with the ICMR and National Institute of Virology in…

A coronavirus vaccine in 40 days, ICMR?

Deccan Herald Misery acquaints us with strange bedfellows. Many years hence, this will perhaps be narrated as an apocryphal story. But for now, the Indian Council of Medical Research (ICMR) appears less the apex body in India for…

How the pandemic has impacted research at a global level

Maria Cohut, Ph.D. The COVID-19 pandemic has turned life, travel, and the economy upside down all around the world. But what impact has it had on research and research practices, in general? In this Special Feature, we investigate….